Lerer B - Search Results

1

Effect of fenfluramine on mood: a double-blind placebo-controlled trial.

Lichtenberg P, Shapira B, Blacker M, Gropp C, Calev A, Lerer B. Lichtenberg P, et al. Among authors: lerer b. Biol Psychiatry. 1992 Feb 15;31(4):351-6. doi: 10.1016/0006-3223(92)90228-r. Biol Psychiatry. 1992. PMID: 1558898 Clinical Trial.

2

Platelet adenylate cyclase activity in depression and after clomipramine and lithium treatment: relation to serotonergic function.

Newman ME, Lerer B, Lichtenberg P, Shapira B. Newman ME, et al. Among authors: lerer b. Psychopharmacology (Berl). 1992;109(1-2):231-4. doi: 10.1007/BF02245505. Psychopharmacology (Berl). 1992. PMID: 1365662 Clinical Trial.

3

Hormone responses to fenfluramine and placebo challenge in endogenous depression.

Lichtenberg P, Shapira B, Gillon D, Kindler S, Cooper TB, Newman ME, Lerer B. Lichtenberg P, et al. Among authors: lerer b. Psychiatry Res. 1992 Aug;43(2):137-46. doi: 10.1016/0165-1781(92)90128-p. Psychiatry Res. 1992. PMID: 1410069 Clinical Trial.

4

Serotonergic mechanisms of ECT: neuroendocrine evidence.

Shapira B, Newman M, Lerer B. Shapira B, et al. Among authors: lerer b. Clin Neuropharmacol. 1992;15 Suppl 1 Pt A:673A-674A. doi: 10.1097/00002826-199201001-00348. Clin Neuropharmacol. 1992. PMID: 1498996 Clinical Trial. No abstract available.

5

Effect of clomipramine and lithium on fenfluramine-induced hormone release in major depression.

Shapira B, Yagmur MJ, Gropp C, Newman M, Lerer B. Shapira B, et al. Among authors: lerer b. Biol Psychiatry. 1992 May 15;31(10):975-83. doi: 10.1016/0006-3223(92)90091-d. Biol Psychiatry. 1992. PMID: 1511080 Clinical Trial.

6

Regulation of 5-hydroxytryptamine1A receptor function in rat hippocampus by short- and long-term administration of 5-hydroxytryptamine1A agonist and antidepressants.

Newman ME, Shapira B, Lerer B. Newman ME, et al. Among authors: lerer b. J Pharmacol Exp Ther. 1992 Jan;260(1):16-20. J Pharmacol Exp Ther. 1992. PMID: 1530973

7

Enhanced serotonergic responsivity following electroconvulsive therapy in patients with major depression.

Shapira B, Lerer B, Kindler S, Lichtenberg P, Gropp C, Cooper T, Calev A. Shapira B, et al. Among authors: lerer b. Br J Psychiatry. 1992 Feb;160:223-9. doi: 10.1192/bjp.160.2.223. Br J Psychiatry. 1992. PMID: 1540763

8

Phospholipase A2 activity in Epstein-Barr virus-transformed lymphoblast cells from schizophrenic patients.

Bennett ER, Yedgar S, Lerer B, Ebstein RP. Bennett ER, et al. Among authors: lerer b. Biol Psychiatry. 1991 Jun 1;29(11):1058-62. doi: 10.1016/0006-3223(91)90247-j. Biol Psychiatry. 1991. PMID: 1651772

9

Performance of long-stay schizophrenics after drug withdrawal on matched immediate and delayed recall tasks.

Calev A, Nigal D, Kugelmass S, Weller MP, Lerer B. Calev A, et al. Among authors: lerer b. Br J Clin Psychol. 1991 Sep;30(3):241-5. doi: 10.1111/j.2044-8260.1991.tb00942.x. Br J Clin Psychol. 1991. PMID: 1681971

10

Optimal use of electroconvulsive therapy: choosing a treatment schedule.

Shapira B, Calev A, Lerer B. Shapira B, et al. Among authors: lerer b. Psychiatr Clin North Am. 1991 Dec;14(4):935-46. Psychiatr Clin North Am. 1991. PMID: 1771155 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

408 results

Search Page

Filters